Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs intravenous droperidol pharmacokinetics in healthy volunteers
ACTRN12614000514606Phase 4Completed
- Sponsor
- Monash Health
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of droperidol (2 arms), sponsored by Monash Health. Primary endpoint: Pharmacokinetic comparison of intranasal and intravenous droperidol. Started Dec 2014; status: completed.
02
Drugs
droperidol
Beyond the preview
Go deeper on ACTRN12614000514606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000514606.